Cambridge sweeps NCRI Excellence Awards

Cambridge researchers win three out of four NCRI Excellence Awards at cancer conference

Congratulations to Cancer Research UK Cambridge Centre members who have won three of the four inaugural National Cancer Research Institute (NCRI) Excellence Awards presented at the NCRI Conference in Glasgow on 4 November.

Paul Pharoah, Centre for Cancer Genetic Epidemiology and Jem Rashbass, Public Health England received the Impact Award for developing the Predict suite of personalised risk communication tools to help doctors and patients to make more informed decisions on cancer treatments.

Predict Breast, the online breast cancer and treatment benefit prediction model, has been accessed across the world nearly 1.25million times since it launched in 2010.

The Paediatric Adolescent Wildtype and Syndromic Gastrointestinal Stromal Tumour (PAWS-GIST) Alliance, which is led by Ramesh Bulusu, Cambridge University Hospitals has been awarded the Collaboration Award.

The PAWS-GIST Alliance brings together patients, carers and health care professionals to raise awareness, improve treatments and further understanding of this rare subgroup of GIST cancers.

Mathew Garnett, Wellcome Sanger Institute received the Innovation Award for his cutting-edge work in the field of translational cancer genomics.

The awards mark the 15th anniversary of the NCRI Conference by awarding the people and teams who have made a great contribution to cancer research and the NCRI Partnership.

5 Nov 2019